Open Access
ARTICLE
miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
* The Department of General Surgery, Tongde Hospital of Zhejiang Province, Zhejiang Province, P.R. China
† The Department of Medical Oncology, The First Hospital of Shijiazhuang, Shijiazhuang, Hebei Province, P.R. China
‡ The Department of Hepatological Surgery, Tongde Hospital of Zhejiang Province, Zhejiang Province, P.R. China